Ligand grants Spectrum exclusive, worldwide rights to develop and commercialize captisol-enabled Melphalan

Ligand Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$466.2m on 03/15/2013 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Spectrum Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$462.5m on 03/15/2013 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced